Clinical trials for Gliosarcoma
21 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGPhase 1NCT07134842A Study Assessing if it is Safe and Possible to Treat Brain Cancer Patients With Immunotherapy Before They Receive the Standard Treatment.University College, London · PI: Paul Mulholland, MBBS, PhD
- ENROLLING BY INVITATIONPhase 1NCT06896110Intrathecal Azacitidine and Nivolumab in Patients With Recurrent High-grade GliomaAndrew P. Groves
- RECRUITINGPhase 1NCT06934889Study of ABBV-637 or ABBV-155 With ERAS-801 for People With GlioblastomaMemorial Sloan Kettering Cancer Center · PI: Thomas Kaley, MD
- RECRUITINGNCT05756985Improving Understanding of Glioblastoma Through Preservation of Biologically Active Brain TissueBaptist Health South Florida · PI: Manmeet S Ahluwalia, M.D.
- RECRUITINGPhase 2NCT05864534Phase 2a Immune Modulation With Ultrasound for Newly Diagnosed GlioblastomaNorthwestern University · PI: Adam Sonabend, MD
- RECRUITINGNCT06954636Prognostic Potential of Olfactory Function in Glioblastoma: a Prospective Observational StudySied Kebir
- RECRUITINGPhase 1NCT04991870Phase I CB-NK-TGF-ßR2-/NR3C1- in rGBMM.D. Anderson Cancer Center · PI: Shiao-Pei S Weathers, MD
- RECRUITINGPhase 1NCT05363826Intracavitary Photodynamic Therapy as an Adjuvant to Resection of Glioblastoma or Gliosarcoma Using IV Photobac®Photolitec LLC · PI: William R Potter, MA
- RECRUITINGPhase 1NCT05857969Ex Vivo Drug Sensitivity Testing and Multi-Omics ProfilingFlorida International University · PI: Diana Azzam
- RECRUITINGPhase 2NCT05465954Efineptakin Alfa and Pembrolizumab for the Treatment of Recurrent GlioblastomaMayo Clinic · PI: Jian L. Campian, MD, PhD
- RECRUITINGPhase 2NCT05052957hSTAR GBM (Hematopoetic Stem Cell (HPC) Rescue for GBM)Leland Metheny · PI: Leland Metheny, MD
- RECRUITINGPHASE1, PHASE2NCT05039281Atezolizumab and Cabozantinib for the Treatment of Recurrent GlioblastomaM.D. Anderson Cancer Center · PI: Shiao-Pei S Weathers
- ACTIVE NOT RECRUITINGEarly Phase 1NCT05091866Natural Progesterone for the Treatment of Recurrent GlioblastomaEmory University · PI: Hui-Kuo G Shu, MD, PhD, FASTRO
- ACTIVE NOT RECRUITINGPhase 3NCT05095376Testing the Addition of the Chemotherapy Drug Lomustine (Gleostine) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated GlioblastomaNRG Oncology · PI: Fabio M Iwamoto
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT04528680Ultrasound-based Blood-brain Barrier Opening and Albumin-bound Paclitaxel and Carboplatin for Recurrent GlioblastomaNorthwestern University · PI: Roger Stupp, MD
- ACTIVE NOT RECRUITINGPhase 1NCT04216329Selinexor (KPT-330) in Combination With Temozolomide and Radiation Therapy in Patients With Newly Diagnosed GlioblastomaNational Cancer Institute (NCI) · PI: Kevin A Camphausen, M.D.
- ACTIVE NOT RECRUITINGPhase 2NCT03197506Pembrolizumab and Standard Therapy in Treating Patients With GlioblastomaMayo Clinic · PI: Ian F. Parney, MD, PhD
- ACTIVE NOT RECRUITINGN/ANCT03115333DSC-MRI in Measuring rCBV for Early Response to Bevacizumab in Patients With Recurrent GlioblastomaECOG-ACRIN Cancer Research Group · PI: Jerrold Boxerman
- ACTIVE NOT RECRUITINGPHASE2, PHASE3NCT02152982Temozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed Glioblastoma MultiformeNational Cancer Institute (NCI) · PI: Jann N Sarkaria
- ACTIVE NOT RECRUITINGPhase 2NCT01903330ERC1671/GM-CSF/Cyclophosphamide for the Treatment of Glioblastoma MultiformeEpitopoietic Research Corporation · PI: Daniela A. Bota, MD, PhD
- ACTIVE NOT RECRUITINGPhase 1NCT00102648Lonafarnib and Temozolomide in Treating Patients with Glioblastoma Multiforme That is Recurrent or Did Not Respond to Previous Treatment with TemozolomideM.D. Anderson Cancer Center · PI: Vinay Puduvalli